Gastrointestinal bleeding from Dieulafoy’s lesion: Clinical presentation, endoscopic findings, and endoscopic therapy

Table 5 Efficacy of endoscopic injection monotherapy for bleeding Dieulafoy’s lesions

Endoscopic procedure(No. of patients)	Lesion location	Type of study	Follow-up	Outcome	Ref.
Epinephrine injection
EGD (16)	Stomach/duodenum	Prospective	1 wk	2 (12%) hemostasis failure, 5 (31%) rebled	[78]
EGD (11) Colonoscopy (1)	Stomach Rectum	Retrospective	22 mo	3 (27%) hemostasis failure, 4 (36%) rebled	[73]
EGD (11)	Stomach/duodenum	Retrospective	18 mo	3 (27%) hemostasis failure, 2 (18%) rebled	[88]
“Mostly” EGD (8)	Mostly stomach/duodenum	Retrospective	Hospitalization	No rebleeding	[36]
EGD (8)	Stomach	Prospective	30 d	6 (75%) rebled	[76]
EGD (6)	Stomach	Retrospective	60 d	2 (33%) hemostasis failure	[40]
EGD (3) Colonoscopy (1)	Stomach/duodenum cecum (1)	Retrospective	14 mo	No rebleeding	[35]
EGD (3)	Stomach	Retrospective	32 mo	2 (66%) rebled	[72]
Absolute ethanol injection
EGD (12)	Stomach/duodenum	Retrospective	69 mo	1 (8%) hemostasis failure, no rebleeding	[89]
Ethanolamine injection
EGD (1)	Stomach	Retrospective	8 mo	Rebled	[72]

EGD: Esophagogastroduodenoscopy.